Cargando…
Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of disorders with progressive loss of photoreceptor and pigment epithelial function. Nineteen unrelated Polish probands clinically diagnosed with nonsyndromic RP were recruited to this study. We used whole-exome sequencing...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954991/ https://www.ncbi.nlm.nih.gov/pubmed/36832217 http://dx.doi.org/10.3390/diagnostics13040730 |
_version_ | 1784894246562562048 |
---|---|
author | Wawrocka, Anna Socha, Magdalena Walczak-Sztulpa, Joanna Koczyk, Grzegorz Skorczyk-Werner, Anna Krawczyński, Maciej R. |
author_facet | Wawrocka, Anna Socha, Magdalena Walczak-Sztulpa, Joanna Koczyk, Grzegorz Skorczyk-Werner, Anna Krawczyński, Maciej R. |
author_sort | Wawrocka, Anna |
collection | PubMed |
description | Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of disorders with progressive loss of photoreceptor and pigment epithelial function. Nineteen unrelated Polish probands clinically diagnosed with nonsyndromic RP were recruited to this study. We used whole-exome sequencing (WES) to identify potential pathogenic gene variants in molecularly undiagnosed RP patients, as a molecular re-diagnosis after having performed targeted NGS in the past. Targeted NGS allowed for identification of the molecular background in only 5 out of 19 patients. Fourteen patients who remained unsolved despite the targeted NGS were subjected to WES. WES revealed potentially causative variants in RP-related genes in another 12 patients. Together, NGS methods revealed the coexistence of causal variants affecting distinct RP genes in 17 out of 19 RP families, with a very high efficiency of 89%. With the improvement of NGS methods, including higher sequencing depth, broader target enrichment, and better bioinformatic analysis capabilities, the ratio of identified causal gene variants has significantly increased. Therefore, it is important to consider repeating high-throughput sequencing analysis in those patients in whom the previously performed NGS did not reveal any pathogenic variants. The study confirmed the efficiency and clinical utility of re-diagnosis with WES in molecularly undiagnosed RP patients. |
format | Online Article Text |
id | pubmed-9954991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99549912023-02-25 Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa Wawrocka, Anna Socha, Magdalena Walczak-Sztulpa, Joanna Koczyk, Grzegorz Skorczyk-Werner, Anna Krawczyński, Maciej R. Diagnostics (Basel) Article Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of disorders with progressive loss of photoreceptor and pigment epithelial function. Nineteen unrelated Polish probands clinically diagnosed with nonsyndromic RP were recruited to this study. We used whole-exome sequencing (WES) to identify potential pathogenic gene variants in molecularly undiagnosed RP patients, as a molecular re-diagnosis after having performed targeted NGS in the past. Targeted NGS allowed for identification of the molecular background in only 5 out of 19 patients. Fourteen patients who remained unsolved despite the targeted NGS were subjected to WES. WES revealed potentially causative variants in RP-related genes in another 12 patients. Together, NGS methods revealed the coexistence of causal variants affecting distinct RP genes in 17 out of 19 RP families, with a very high efficiency of 89%. With the improvement of NGS methods, including higher sequencing depth, broader target enrichment, and better bioinformatic analysis capabilities, the ratio of identified causal gene variants has significantly increased. Therefore, it is important to consider repeating high-throughput sequencing analysis in those patients in whom the previously performed NGS did not reveal any pathogenic variants. The study confirmed the efficiency and clinical utility of re-diagnosis with WES in molecularly undiagnosed RP patients. MDPI 2023-02-14 /pmc/articles/PMC9954991/ /pubmed/36832217 http://dx.doi.org/10.3390/diagnostics13040730 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wawrocka, Anna Socha, Magdalena Walczak-Sztulpa, Joanna Koczyk, Grzegorz Skorczyk-Werner, Anna Krawczyński, Maciej R. Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa |
title | Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa |
title_full | Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa |
title_fullStr | Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa |
title_full_unstemmed | Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa |
title_short | Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa |
title_sort | molecular re-diagnosis with whole-exome sequencing increases the diagnostic yield in patients with non-syndromic retinitis pigmentosa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954991/ https://www.ncbi.nlm.nih.gov/pubmed/36832217 http://dx.doi.org/10.3390/diagnostics13040730 |
work_keys_str_mv | AT wawrockaanna molecularrediagnosiswithwholeexomesequencingincreasesthediagnosticyieldinpatientswithnonsyndromicretinitispigmentosa AT sochamagdalena molecularrediagnosiswithwholeexomesequencingincreasesthediagnosticyieldinpatientswithnonsyndromicretinitispigmentosa AT walczaksztulpajoanna molecularrediagnosiswithwholeexomesequencingincreasesthediagnosticyieldinpatientswithnonsyndromicretinitispigmentosa AT koczykgrzegorz molecularrediagnosiswithwholeexomesequencingincreasesthediagnosticyieldinpatientswithnonsyndromicretinitispigmentosa AT skorczykwerneranna molecularrediagnosiswithwholeexomesequencingincreasesthediagnosticyieldinpatientswithnonsyndromicretinitispigmentosa AT krawczynskimaciejr molecularrediagnosiswithwholeexomesequencingincreasesthediagnosticyieldinpatientswithnonsyndromicretinitispigmentosa |